Contact Information: Contact: Christina Guilbert Klaubert InkHouse (for Virtify) 781-916-9090
MEDIA ADVISORY: Virtify, Inc. CEO and Founder, Dr. Satish Tadikonda to Speak at ACG Boston Fall Conference
| Source: Virtify
CAMBRIDGE, MA--(Marketwire - November 13, 2009) - Virtify, Inc., the market leader in
enterprise content compliance software solutions for life sciences
companies, will be a featured participant at the upcoming ACG Boston Fall
Conference and Private Company Showcase on Tuesday, November 17th. The
conference highlights healthcare investment and technology trends and
spotlights local high growth healthcare IT companies that are transforming
the healthcare industry by helping to reduce healthcare expenditures,
improve clinical outcomes, and increase access to quality care.
The Association for Corporate Growth (ACG) is an individual- and
company-based organization focused on mergers and acquisitions and
corporate growth. ACG Boston members include corporate executives, private
equity and venture capital investors, investment bankers, and service
professionals.
Virtify CEO and founder, Dr. Satish Tadikonda, will speak at the event and
discuss how Virtify's solutions are helping life sciences companies
accelerate the approval and availability of important new drug discoveries
and ensure patient safety while reducing operational expenses. Other
presenters at the event include senior executives from Cambridgesoft,
Healthfusion, NaviNet and Picis.
The cost of bringing a new drug to market today ranges from $800 million to
$1.2 billion and it's estimated that roughly 26% of that cost comes from
the content requirements associated with regulatory compliance according to
industry analyst IDC. Many companies find themselves ill-equipped to cope
with an increasingly complex regulatory environment because of fragmented,
paper-based-processes that make timely postings and filings nearly
impossible. The impact of non-compliance is significant, and includes
costly product delays, regulatory fines, and lost market opportunities. As
a result, life science companies are increasingly looking towards
technologies like Virtify's that can help them automate their regulatory
submission processes and ensure compliance with the many different global
standards and regulatory mandates.
The ACG Conference runs from 12:30 PM to 4:30 PM on Tuesday November 17th
at the Seaport World Trade Center in downtown Boston. Presentations will
begin promptly at 1:00 PM. There is a networking reception immediately
following the conference program. More information and pre-registration is
available at ACG Boston Fall Conference 2009.
About Virtify
Virtify is the market leader in Enterprise Content Compliance software
solutions for life sciences. Organizations rely on Virtify solutions to
reduce time-to-market, risk, and costs by managing and automating the
complex regulatory compliance and content exchange requirements throughout
the product life cycle. Virtify's easy-to-use Virtx software suite is the
industry's only solution to provide a secure, collaborative web-based
environment for managing regulated content throughout the entire continuum
-- from pre-clinical through product registration to commercialization. The
company plays a leadership role in the development of global regulatory
standards and is an active participant in a variety of standards
committees. Virtify's software products combined with comprehensive
professional services and deep domain expertise enhance quality and
compliance for some of the world's leading life sciences companies. Located
on the Web at www.virtify.com.